PharmEasy’s FY24 Loss Halves To INR 2,531 Cr

PharmEasy’s FY24 loss halved to INR 2,531 crore, reflecting improved operational efficiency and cost management. The online pharmacy and healthcare platform reported significant growth in its user base and transaction volumes, driven by increased demand for digital health services. PharmEasy’s efforts to streamline its supply chain and optimize its operations contributed to the reduced losses. The company plans to continue investing in technology and expanding its service offerings to drive further growth. The financial performance highlights PharmEasy’s progress towards achieving profitability and its position as a leading player in India’s digital healthcare market.